QC
AGL icon

Quadrature Capital’s Agilon Health AGL Stock Holding History

Quadrature Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,155
Closed -$158K – 1230
2025
Q3 		$158K Buy
+6,155
New +$233K ﹤0.01% 820
2025
Q2 		– Sell
-2,589
Closed -$280K – 1013
2025
Q1 		$280K Buy
2,589
+702
+37% +$61.1K 0.01% 757
2024
Q4 		$89.4K Sell
1,887
-775
-29% -$46.9K ﹤0.01% 927
2024
Q3 		$261K Buy
+2,662
New +$344K 0.01% 689
2024
Q2 		– Sell
-1,215
Closed -$185K – 1096
2024
Q1 		$185K Buy
+1,215
New +$202K ﹤0.01% 1056
2022
Q4 		– Sell
-1,065
Closed -$624K – 829
2022
Q3 		$624K Buy
+1,065
New +$638K 0.02% 463

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return